SwineFarming.org

Home › Articles › Swine Health Deep Dives › Colistin Resistance: The End of a Last-Resort Drug?

Swine Health Deep Dives

Colistin Resistance: The End of a Last-Resort Drug?

Colistin is an old polymyxin antibiotic that fell out of favor in human medicine for its toxicity, then returned as a last-resort treatment for infections caused by multidrug-resistant bacteria. In pig production, it has been widely used, especially in many countries, against post-weaning E. coli diarrhea. In 2015, researchers reported a transferable colistin resistance gene, mcr-1, that had been found in pigs and then in people, and the discovery changed policy worldwide. This article explains what happened, why it matters and what producers can do.

What colistin is and why it matters

Colistin (polymyxin E) is a polypeptide antibiotic that damages the outer membrane of gram-negative bacteria. It is poorly absorbed from the gut, which made it attractive for treating intestinal infections in pigs. In human medicine, it is reserved for serious infections, such as those caused by carbapenem-resistant organisms, when few other options remain.

The World Health Organization classifies colistin among the highest-priority critically important antimicrobials. That designation makes any loss of effectiveness a public health concern, and it explains why veterinary use has attracted scrutiny.

The discovery of mcr-1

Until 2015, colistin resistance was believed to arise mainly through chromosomal mutations in individual bacteria, which spread slowly. Then researchers in China identified a plasmid-borne gene, mcr-1, in E. coli from pigs, pork and human patients. A plasmid is a mobile piece of DNA that bacteria can share, even between species.

Since then, mcr-1 and later variants (mcr-2 and beyond) have been found around the world in animals, food, people and the environment. Detection in a country does not tell us the direction or frequency of transfer, but the finding made clear that heavy colistin use in livestock could encourage a resistance gene that threatens human medicine.

Policy responses

Governments responded in several ways:

  • China banned colistin as a growth promoter in 2017 and later restricted its veterinary use
  • The European Union has recommended sharp reductions in colistin use in animals and set targets for decreases
  • Many countries restricted or banned non-therapeutic uses and moved to prescription-only access
  • Several countries monitor resistance in animals and food through national surveillance programs

Reported reductions in sales and in mcr-1 prevalence in some countries after restrictions suggest that policy can work. Check current rules in your country; in the United States, colistin is not approved for use in food-producing animals, and extra-label use is limited, so confirm with your veterinarian.

Why pigs were central

Pig production relied on polymyxins, usually in feed or water, for years. Weaning is a high-risk period: abrupt diet changes, social stress and a developing gut set the stage for E. coli scours (see Pig Scours and Diarrhea: Causes by Age, Treatment and Prevention). Colistin, along with zinc oxide, was a standard answer in many systems.

Heavy group medication selects strongly for resistance, since every pig in the group is exposed, including the healthy majority. This is why stewardship focuses on reducing flock-wide, long-duration, low-dose use. See Antimicrobial Stewardship: Reducing In-Feed Antibiotics for the general framework and Water-Medicated Treatment: Dosage Accuracy and Delivery for how delivery accuracy affects selection.

Reducing reliance without losing pigs

Producers who cut back on colistin or similar drugs do so by preventing the problem it was used to treat. A common approach combines several changes:

  1. Improve weaning management, including age, weight and feed access; see Weaning Piglets: Age, Methods, Nursery Care and Avoiding Setbacks and Weaning Stress: Behavioral Indicators
  2. Adjust starter diets, protein levels and fiber, as in Weaned Pig Starter Diets: Complexity vs. Cost
  3. Use organic acids and other additives with veterinary guidance; see Organic Acids in Swine Diets: Mode of Action and Dosage
  4. Provide clean water and sanitized lines, as in Water Line Sanitation: Biofilm and Pathogen Risks
  5. Vaccinate where an effective product exists
  6. Improve barn climate and cleaning between groups

Zinc oxide has its own restrictions and environmental issues, so replacing one with the other is not an answer; see Alternatives to Zinc Oxide in Weaned Pig Diets.

What producers should do now

The practical rules are straightforward:

  • Use antimicrobials only under a valid veterinarian-client-patient relationship, described in Veterinary-Client-Patient Relationship: Compliance
  • Ask for culture and sensitivity results before treating outbreaks
  • Treat the smallest effective group for the shortest time the label and veterinarian recommend
  • Record every treatment and respect withdrawal times
  • Avoid products that are not approved or labeled for your pigs and your country

If your operation sells into export or premium markets, buyers may require records proving that critically important drugs are not used. See Antibiotic-Free Claims: Market Premium for how labels and programs work.

Is it really the end of a last-resort drug?

The honest answer is that colistin's future is uncertain but not hopeless. Resistance genes persist, and in some regions, mcr genes remain common. Yet several national programs have seen reductions in resistance after use dropped. Gene presence in animals does not by itself prove that animals are the main source for human infections; human use, hospital transmission and environmental spread are also important.

Resistance often has a fitness cost for bacteria, meaning that when pressure is removed, resistant types sometimes decline. That is the logic behind the policy approach. Research into alternatives, new antibiotics and better diagnostics continues.

One Health perspective

Antimicrobial resistance crosses boundaries between pigs, people and the environment. Manure spread on fields, waste water, food and direct contact can all transport resistant bacteria. For that reason, health agencies speak of One Health: coordinated action across veterinary, medical and environmental sectors.

Pig farmers are part of the solution when they measure use, prevent disease, and treat prudently. Related examples are MRSA in Swine: Human Health Concerns and Salmonella Control at the Farm Level: A Practical Roadmap. For policy updates, consult the National Pork Board and your veterinarian.

FAQ

Can I use colistin on my pigs in the United States?

Colistin is not approved for food animals in the United States, and extra-label use is tightly limited. Confirm what is legal with your veterinarian.

What is the mcr-1 gene?

It is a mobile gene that makes bacteria resistant to colistin and can move between bacteria on plasmids. It was first reported in 2015 in bacteria from pigs and people.

How can weaned pigs be managed with less colistin?

Focus on weaning age and weight, diet design, clean water, barn climate, hygiene and vaccination, with your veterinarian guiding any treatment.

Keep learning

Browse all 700 guides →